Psychiatry in Goose Creek, SC
5 verified psychiatry doctors in Goose Creek.
Psychiatrists are physicians who diagnose and treat mental health conditions, including through medication management.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the South Carolina Board of Medical Examiners
Dr. Joseph Coll, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Deena Flessas, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Melanie Hatzis, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Joseph Cockrell, MD
Psychiatry
CMS Open Payments· $102.03 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$102.03
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total ranks around the 84th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Joseph Cockrell do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Anthony Romero, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.